Ab&B Biotech

company

About

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

  • 251 - 500

Details

Last Funding Type
Series C
Last Funding Money Raised
$92.73M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
251 - 500
Operating Status
Active

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$92.73M
Ab&B Biotech has raised a total of $92.73M in funding over 2 rounds. Their latest funding was raised on Jul 16, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 16, 2021 Series C $92.73M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Ab&B Biotech is funded by 2 investors. Sanhua Hongdao Investment and Puxin Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sanhua Hongdao Investment Series C
Puxin Capital Series C